PMID- 19304863 OWN - NLM STAT- MEDLINE DCOM- 20110111 LR - 20191210 IS - 1461-7285 (Electronic) IS - 0269-8811 (Linking) VI - 24 IP - 9 DP - 2010 Sep TI - mCPP: an undesired addition to the ecstasy market. PG - 1395-401 LID - 10.1177/0269881109102541 [doi] AB - A new ecstasy-like substance, meta-chlorophenylpiperazine (mCPP), has been detected in street drugs in the Netherlands. Theoretically, mCPP possesses the potential to become a non-neurotoxic alternative for methylenedioxymethamphetamine (MDMA), the regular psychoactive substance of ecstasy. Since its introduction on the Dutch market of synthetic drugs, the percentage of mCPP-containing tablets has increased, including both tablets that contain only mCPP and tablets containing a combination of mCPP and MDMA. These tablets occur in many different colours, shapes and sizes and with various logos, making it impossible to distinguish mCPP-containing tablets from regular MDMA tablets. In addition, the reports of users concerning the effects of mCPP are predominantly negative. All these aspects together lead to the conclusion that mCPP is an undesired addition to the ecstasy market from the user's perspective. FAU - Bossong, M G AU - Bossong MG AD - Drug Information and Monitoring System (DIMS), Trimbos Institute for Mental Health and Addiction, Utrecht, The Netherlands. M.Bossong@umcutrecht.nl FAU - Brunt, T M AU - Brunt TM FAU - Van Dijk, J P AU - Van Dijk JP FAU - Rigter, S M AU - Rigter SM FAU - Hoek, J AU - Hoek J FAU - Goldschmidt, H M J AU - Goldschmidt HM FAU - Niesink, R J M AU - Niesink RJ LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20090320 PL - United States TA - J Psychopharmacol JT - Journal of psychopharmacology (Oxford, England) JID - 8907828 RN - 0 (Drug Combinations) RN - 0 (Hallucinogens) RN - 0 (Illicit Drugs) RN - 0 (Piperazines) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) RN - REY0CNO998 (1-(3-chlorophenyl)piperazine) SB - IM MH - Drug Combinations MH - Gas Chromatography-Mass Spectrometry MH - *Hallucinogens/adverse effects/analysis/chemistry MH - Humans MH - *Illicit Drugs/adverse effects/analysis/chemistry MH - N-Methyl-3,4-methylenedioxyamphetamine/adverse effects/analysis/chemistry MH - Netherlands MH - *Piperazines/adverse effects/analysis/chemistry EDAT- 2009/03/24 09:00 MHDA- 2011/01/12 06:00 CRDT- 2009/03/24 09:00 PHST- 2009/03/24 09:00 [entrez] PHST- 2009/03/24 09:00 [pubmed] PHST- 2011/01/12 06:00 [medline] AID - 0269881109102541 [pii] AID - 10.1177/0269881109102541 [doi] PST - ppublish SO - J Psychopharmacol. 2010 Sep;24(9):1395-401. doi: 10.1177/0269881109102541. Epub 2009 Mar 20.